Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis
This study is not yet open for participant recruitment.
Study NCT00889967   Information provided by Aradigm Corporation
First Received: April 27, 2009   Last Updated: April 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Non-Cystic Fibrosis Bronchiectasis
Additional conditions recognized in this trial
Bronchiectasis
Fibrosis
More general conditions related to this trial
Bronchial Diseases
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
Ciprofloxacin for Inhalation
Placebo
Additional drug interventions recognized in this trial
Ciprofloxacin
More general drug interventions related to this trial
Anti-Infective Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Aradigm Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services